These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25888220)

  • 1. Clinical outcome, biochemical and therapeutic follow-up in 14 Austrian patients with Long-Chain 3-Hydroxy Acyl CoA Dehydrogenase Deficiency (LCHADD).
    Karall D; Brunner-Krainz M; Kogelnig K; Konstantopoulou V; Maier EM; Möslinger D; Plecko B; Sperl W; Volkmar B; Scholl-Bürgi S
    Orphanet J Rare Dis; 2015 Feb; 10():21. PubMed ID: 25888220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral neuropathy in patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency - A follow-up EMG study of 12 patients.
    Immonen T; Ahola E; Toppila J; Lapatto R; Tyni T; Lauronen L
    Eur J Paediatr Neurol; 2016 Jan; 20(1):38-44. PubMed ID: 26653362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Energy exchangers with LCT as a precision method for diet control in LCHADD.
    Mozrzymas R; Konikowska K; Regulska-Ilow B
    Adv Clin Exp Med; 2017; 26(3):515-525. PubMed ID: 28791828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Newborn Screening and Early Dietary Management on Clinical Outcome of Patients with Long Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency and Medium Chain Acyl-CoA Dehydrogenase Deficiency-A Retrospective Nationwide Study.
    Rücklová K; Hrubá E; Pavlíková M; Hanák P; Farolfi M; Chrastina P; Vlášková H; Kousal B; Smolka V; Foltenová H; Adam T; Friedecký D; Ješina P; Zeman J; Kožich V; Honzík T
    Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fasting, feeding and exercise on plasma acylcarnitines among subjects with CPT2D, VLCADD and LCHADD/TFPD.
    Elizondo G; Matern D; Vockley J; Harding CO; Gillingham MB
    Mol Genet Metab; 2020; 131(1-2):90-97. PubMed ID: 32928639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Earlier diagnosis and strict diets improve the survival rate and clinical course of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
    Immonen T; Turanlahti M; Paganus A; Keskinen P; Tyni T; Lapatto R
    Acta Paediatr; 2016 May; 105(5):549-54. PubMed ID: 26676313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle MRI in patients with long-chain fatty acid oxidation disorders.
    Diekman EF; van der Pol WL; Nievelstein RA; Houten SM; Wijburg FA; Visser G
    J Inherit Metab Dis; 2014 May; 37(3):405-13. PubMed ID: 24305961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retained visual function in a subset of patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD).
    Dulz S; Atiskova Y; Engel P; Wildner J; Tsiakas K; Santer R
    Ophthalmic Genet; 2021 Feb; 42(1):23-27. PubMed ID: 33107778
    [No Abstract]   [Full Text] [Related]  

  • 9. Most patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency develop pathological or subnormal retinal function.
    Fahnehjelm KT; Liu Y; Olsson D; Amrén U; Haglind CB; Holmström G; Halldin M; Andreasson S; Nordenström A
    Acta Paediatr; 2016 Dec; 105(12):1451-1460. PubMed ID: 27461099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spectrum of peripheral neuropathy in disorders of the mitochondrial trifunctional protein.
    Grünert SC; Eckenweiler M; Haas D; Lindner M; Tsiakas K; Santer R; Tucci S; Spiekerkoetter U
    J Inherit Metab Dis; 2021 Jul; 44(4):893-902. PubMed ID: 33638202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic, biochemical, and clinical spectrum of patients with mitochondrial trifunctional protein deficiency identified after the introduction of newborn screening in the Netherlands.
    Schwantje M; Fuchs SA; de Boer L; Bosch AM; Cuppen I; Dekkers E; Derks TGJ; Ferdinandusse S; Ijlst L; Houtkooper RH; Maase R; van der Pol WL; de Vries MC; Verschoof-Puite RK; Wanders RJA; Williams M; Wijburg F; Visser G
    J Inherit Metab Dis; 2022 Jul; 45(4):804-818. PubMed ID: 35383965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early diagnosis and treatment by newborn screening (NBS) or family history is associated with improved visual outcomes for long-chain 3-hydroxyacylCoA dehydrogenase deficiency (LCHADD) chorioretinopathy.
    Gillingham MB; Choi D; Gregor A; Wongchaisuwat N; Black D; Scanga HL; Nischal KK; Sahel JA; Arnold G; Vockley J; Harding CO; Pennesi ME
    J Inherit Metab Dis; 2024 Jul; 47(4):746-756. PubMed ID: 38623632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical course and cardiovascular outcomes in patients with the long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency.
    Kwiatkowska J; Wierzba J; Karaszewska A; Kozlowski D; Sykut-Cegielska J; Stanko A
    Cardiol J; 2017; 24(1):101-104. PubMed ID: 28245050
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of Chorioretinopathy Associated with Mitochondrial Trifunctional Protein Disorders: Long-Term Follow-up of 21 Cases.
    Boese EA; Jain N; Jia Y; Schlechter CL; Harding CO; Gao SS; Patel RC; Huang D; Weleber RG; Gillingham MB; Pennesi ME
    Ophthalmology; 2016 Oct; 123(10):2183-95. PubMed ID: 27491397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased and early lipolysis in children with long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency during fast.
    Haglind CB; Nordenström A; Ask S; von Döbeln U; Gustafsson J; Stenlid MH
    J Inherit Metab Dis; 2015 Mar; 38(2):315-22. PubMed ID: 25141826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncoupling, metabolic inhibition and induction of mitochondrial permeability transition in rat liver mitochondria caused by the major long-chain hydroxyl monocarboxylic fatty acids accumulating in LCHAD deficiency.
    Hickmann FH; Cecatto C; Kleemann D; Monteiro WO; Castilho RF; Amaral AU; Wajner M
    Biochim Biophys Acta; 2015; 1847(6-7):620-8. PubMed ID: 25868874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety of Lipistart, a medium-chain triglyceride based formula, in the dietary treatment of long-chain fatty acid disorders: a phase I study.
    MacDonald A; Webster R; Whitlock M; Gerrard A; Daly A; Preece MA; Evans S; Ashmore C; Chakrapani A; Vijay S; Santra S
    J Pediatr Endocrinol Metab; 2018 Mar; 31(3):297-304. PubMed ID: 29425111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial bioenergetics deregulation caused by long-chain 3-hydroxy fatty acids accumulating in LCHAD and MTP deficiencies in rat brain: a possible role of mPTP opening as a pathomechanism in these disorders?
    Tonin AM; Amaral AU; Busanello EN; Gasparotto J; Gelain DP; Gregersen N; Wajner M
    Biochim Biophys Acta; 2014 Sep; 1842(9):1658-67. PubMed ID: 24946182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired Fat Oxidation During Exercise in Long-Chain Acyl-CoA Dehydrogenase Deficiency Patients and Effect of IV-Glucose.
    Madsen KL; Stemmerik MG; Buch AE; Poulsen NS; Lund AM; Vissing J
    J Clin Endocrinol Metab; 2019 Sep; 104(9):3610-3613. PubMed ID: 30990523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive HADHA c.1528G>C frequency study reveals high prevalence of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency in Poland.
    Piekutowska-Abramczuk D; Olsen RK; Wierzba J; Popowska E; Jurkiewicz D; Ciara E; Ołtarzewski M; Gradowska W; Sykut-Cegielska J; Krajewska-Walasek M; Andresen BS; Gregersen N; Pronicka E
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S373-7. PubMed ID: 20814823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.